Product Wiki · Recalls · Health Canada — Medical Devices

ADVIA Centaur System - Folate Assay (2019-07-29) — recall 59819

Health Canada — Medical Devices · Canada · 2019-08-16 · Type III

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
59819
Date of alert
2019-08-16
Country / jurisdiction
Canada
Risk level
Type III
Risk type
recall
Product category
Medical devices
Product type
Medical devices
Reported risk: Siemens Healthcare Diagnostics has confirmed the potential for the ADVIA Centaur homocysteine assay (100 test kit smn 10310374; 500 test kit smn 10310375) to intermittently interfere with the folate assay when testing is performed on the ADVIA Centaur, ADVIA Centaur XP or ADVIA Centaur XPT systems. The interference is observed intermittently with only the first replicate of folate when the assay is tested immediately following homocysteine assay testing.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/advia-centaur-system-folate-as

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.